Hypothesis: We have proposed that VEG/PF acts by transforming the cytoskeletal architecture of microvascular endothelial cells.
INTRODUCTION
A number of common mediators of inflammation and microvascular extravasation have previously been implicated in tumor edemagenesis [1] [2] [3] [4] [5] [6] . Studies demonstrating vascular endothelial growth/permeability factor (VEG/PF)b mRNA expression, and VEG/PF protein expression and secretion, support VEG/PF's role in the genesis of malignant effusions such as ascites, pleural effusions, tissue edema, and the edema accompanying many systemic and central nervous system neoplasms . VEG/PF is expressed by benign and malignant tumors alike, and its presence correlates closely with the presence and extent of microvascular extravasation in the form of peritumoral edema or tumor cyst formation [6, 14, 28, 29] . VEG/PF acts specifically on vascular endothelial cells and has recently been implicated in the pathogenesis of aneurysms and vascular malformations arising in the central nervous system [15, 19, 20, 24, [31] [32] [33] [34] [35] 55] . Its pluralistic actions are essential for tumor growth, as it facilitates both the rapid proliferation of blood vessels (angiogenesis), and a means of developing the extracellular fibrin matrix (microvascular extravasation or edemagenesis) requisite for the ingrowth of new tumor elements.
Actin is one of the three major constituents of the cytoskeleton. The actin cytoskeleton of endothelial cells plays essential roles in cellular function. Whereas its participation in cellular motility, chemotaxis, and cell division appears most relevant to angiogenesis, its role in cellular secretion, endocytosis and permeability more likely relate to edemagenesis. Actin fibers play an essential role in cell dynamics and the maintenance of cell shape. Any change in cellular shape can therefore be expected to be accompanied, if not dictated, by a structural and functional change in actin protein conformation. Regulation of actin's repertoire of cellular functions is only partially understood. It involves interactions with a variety of specific actin binding or regulatory proteins which modulate intracellular calcium flux, protein phosphorylation, and ultimately, the balance between the monomeric (G-actin) and polymerized (F-actin) forms. The studies described herein were designed to ascertain and characterize the effects of VEG/PF perturbation on the endothelial actin cytoskeleton, and to explore this cytocontractile mechanism as a plausible target for dexamethasone's clinical efficacy.
MATERIALS AND METHODS

Working hypothesis, rationale and objectives
We hypothesized that VEG/PF acts by changing endothelial cellular shape by an actin cytoskeletal contractile mechanism [14] [15] [16] . Actin fibers are crucial components of the cytoskeleton in living cells. By altering their three-dimensional structural conformation, actin molecules can regulate motility, shape, and vesicular transport in vascular endothelial cells [4, 23, [36] [37] [38] [39] [40] . VEG/PF is capable of inducing cytosolic calcium transients in endothelial cells [16] . Actin, in turn, interacts with a variety of calcium-activated proteins. The actin state of polymerization is readily studied by rhodamine phalloidin fluorescence staining [39, [41] [42] [43] . Highly polymerized filamentous actin (F-actin) forms a structural network of stress fibers throughout the endothelial plasmalemma, whereas actin depolymerization into the monomeric or globular (G-actin) form results in a bright diffuse "ground glass" staining pattern without apparent structural integrity.
Our experimental objectives were: (1) to examine and define histamine-induced effects on endothelial actin stress fibers, in order to serve as positive controls, (2) to establish, define, and interpret VEG/PF-induced effects on endothelial F-actin stress fibers, and (3) to determine whether dexamethasone exhibited any inhibitory action on VEG/PFinduced actin changes. Rat brain microvascular endothelial cells (RBMVEC) were isolated and characterized in our laboratory employing a previously described method [44] . Four 3-month-old female white Lewis rats were anesthetized with Nembutal and thereafter decapitated. The rat brains were extracted using sterile surgical instruments and immediately immersed in an oxygenated sterile buffer solution consisting of HBSS with 10 mM HEPES buffer, 100 U/ml Penicillin, 100 pg/ml Streptomycin and 0.5 percent bovine serum albumin (BSA).
Rat brains were isolated in a sterile environment and minced into 2 to 3 mm pieces in a separate beaker containing buffer solution. The resultant mixture was transfered into a sterile tube and centrifuged 5 min at 1500 rpm. The buffer was poured off and the cortex tissue placed in an oxygenated enzyme solution consisting of HBSS containing 1 mg/100 ml collagenase/dispase (Boerhinger Mannheim, Indianapolis, IN), 10 mM HEPES buffer, 100 U/ml Penicillin, 100 pg/ml Streptomycin, 0.147 pg/ml TLCK (Sigma, St. Louis, MO) and 20 U/ml DNase (Boerhinger Mannheim, Indianapolis, IN) at 37°C for 1 hr. The resultant solution was aspirated up and down a Pasteur pipet to produce a suspension that was centrifuged again at 1500 rpm for 5 min. The supernatant was poured off and the pellet mixed with a 25 percent BSA solution after which this mixture was centrifuged again for 15 min at 2900 rpm. The latter step resulted in the separation of myelin from a capillary pellet at the bottom of the tube. The myelin-rich supernatant was poured off and the capillary pellet resuspended in buffer solution that was centrifuged for five min at 1500 rpm. The buffer was poured off and the pellet was incubated with the enzyme solution at 37°C for 3 hr. Two sterile ultracentrifuge tubes were then.coated with protein by filling them with buffered BSA solution and gently shaking them for 20 min. Both were filled with a 50 percent isotonic percoll (Sigma, St. Louis, MO) mixture that was centrifuged for 1 hr at 16500 rpm. The cell-containing enzyme digest was centrifuged again for -5 min at 1500 rpm and thereafter the enzyme mix was poured off the resulting pellet. The pellet was resuspended in 2 ml of buffer, of which each half was gently dribbled on to the percoll gradients. These gradients were centrifuged again for 15 min at 2900 rpm. A Pasteur pipet was used to extract the capillary pellet bands from the tubes. These were mixed with buffer solution again and centrifuged for 5 min at 1500 rpm. The buffer solution was poured of and the cells mixed with culture medium consisting of HAMS nutrient mixture (Gibco, Grand island, NY) with 20 percent lymphocyte culture serum (Hyclone Labs, Logan, UT), 100 U/ml Penicillin, 100 pg/ml Streptomycin and 2 mM glutamine. The cells were plated on fibronectin-coated plastic tissue culture dishes and left to grow in an incubator with frequent changes of the culture medium for 1 to 2 weeks.
The identity of the endothelial cell cultures was confirmed by the typical "cobblestone" (HUVEC) or "spindle" (RBMVEC) morphology, the F-actin distribution pattern of individual cells, and specific staining for both Factor VIII and di-acetylated-LDL. Contaminating cells (astroglia, smooth muscle, pericytes) were identified by specific staining for glial fibrillary acidic protein (GFAP), HAM-56, alpha-smooth muscle actin (alpha-SMA), and gamma-glutamyl transpeptidase (GGT). Cultures were randomly selected at regular intervals and screened for cellular homogeneity. Experiments were routinely performed on cultures exhibiting over 95 percent purity for vascular endothelial cells.
Rhodamine phalloidin fluorescence staining
Rhodamine-phalloidin, a fluorescent derivative of the phallotoxin from Amantia phalloides, binds with high affinity to F-actin fibers. Ten microliters of rhodamine phalloidin (Molecular Probes, Eugene, OR) was evaporated in a small test tube and redissolved in 200 ul of PBS. Slides with fixed endothelial cells were covered with the rhodamine phalloidin solution for 20 minutes in a dark environment. Then, a 1:1 volume glycerol/PBS antifade reagent was placed on the cells, and a coverslip mounted on top. The cells were examined by fluorescence microscopy using an Olympus BH-2 fluorescence microscopy system matched to an Olympus PM-lOAD photomicrographic system (Olympus Corporation, Lake Success, NY). Experimental design and data analysis VEG/PF165, the most biologically potent and abundant VEG/PF isoform (Genentech, San Francisco, CA), has been used for all experiments described herein. Several different concentrations of VEG/PF (10-9 to 10-7 M) or histamine (10-8 to 10-6 M) were added to the endothelial cell containing wells and incubated for varying intervals (1, 2, 5, and 10 min), after which they w-re fixed in a 4 percent paraformaldehyde (PFH) solution in full medium and left in tht incubator for 15 min. After removing the PFH, the fixed cells were washed extensively with HBSS. Negative control groups were exposed to a volume of HBSS Microscopic examination of all slides was conducted by the two investigators who simultaneously viewed each slide and made comparisons between negative controls (HBSS), positive controls (histamine), and three experimental groups consisting of (1) VEG/PF treated, (2) dexamethasone-VEG/PF treated, and (3) Figure 2) . VEG/PF studies After addition of nanomolar concentrations of VEG/PF, previously confluent endothelial cell monolayers responded with an extensive reorganization of actin stress fibers and cell retraction, with shrinkage and "rounding up" of their cell profile, and a marked widening of the interendothelial spaces. This response was rapid, with maximal actin changes occurring within 1 min of VEG/PF perturbation and complete reversal of the actin changes within 5 min). Diffusely fluorescent "ground glass" perinuclear staining and cellular clumping occurred typically (Figures 3A-C) . In several instances, the endothelial cell plasmalemma exhibited a thickened, intensely staining peripheral band with a characteristic "ruffled" appearance ( Figure 3D ). Despite extensive cellular shrinkage and distortion, cell-to-cell contacts in the form of actin plasmalemmal microspikes were sometinmes maintained, except in the most severely contracted cells (Figures 3B-D ). There were no major qualitative or quantitative differences between the HUVEC and RBMVEC groups in their response to VEG/PF perturbation, except for the more spindlelike appearance of the RBMVEC both before and after perturbation ( Figures IC and 3C ). In cells that showed a partial response, the actin dissolution was most obvious around the cell nucleus, thereby suggesting that depolymerization of actin fibers is initiated in this area. Dose-response experiments revealed progressively higher VEG/PF concentrations (10-9 to 10-6 M) to increase the extent of actin reorganization (pictorial data not shown). Overall, the endothelial actin changes induced by VEG/PF exhibited a structural similarity to those evoked by histamine treatment. Implicit in the current discussion, as in prior discussions by the author, is the premise that VEG/PF-induced edemagenesis and angiogenesis have already been defined as not taking place in microvessels with homotypical blood-brain barrier features. The pathogenesis of peritumoral vasogenic edema is a only partially understood. Extravasated plasma fluid, electrolytes and proteins originate exclusively from the brain tumor microvasculature which differs both morphologically and physiologically from normal blood-brain barrier microvessels [47] [48] [49] [50] [51] [52] [53] . VEG/PF and other permeability mediators appear only to affect capillaries that do not exhibit homotypical blood-brain barrier features [14] . It has been hypothesized that their action on the normal brain microvasculature is mechanistically inhibited by the physical expression of pentalaminar tight-junctions between brain endothelial cells [14, 15] . Although phenotypic differences in brain tumor microvessels likely contribute to the increased permeability seen in the setting of peritumoral vasogenic edema, the mechanisms by which these vascular alterations either occur, or are sustained have hitherto been elusive. Phenotypic expression of tight junctions and other barrier features is contextual, and requires the establishment of physical contacts between brain endothelial cells and normal astroglial cells. Divergence from the typical barrier endothelial phenotype, as seen in brain tumors, appears to correlate with the extent of malignant astrocytic degeneration. Microvessels in low-grade gliomas exhibit more typical, albeit altered blood-brain barrier features, while those associated with highly malignant anaplastic astrocytomas and glioblastoma multiforme bear no semblance to normal blood-brain barrier microvessels and maintain many functional and phenotypic similarities to systemic microvessels [14, 15] . It is based upon our existing knowledge of these functional and phenotypic differences that we feel justified studying the action of VEG/PF action in other "unspecialized" endothelial cells such as HUVECs, or RBMECs that have not been cocultured with normal astroglial cells. Hence, despite their different sites of origin, cultured HUVEC and RBMVEC likely share much in common both with each other and with brain tumor microvessels. The tissue culture environ essentially allows them to revert to a more generic phenotype lacking specialized "barrier" features. It follows, that experiments using endothelial cells with preserved homotypical blood-brain barrier features, would not acurately depict the actual neoangiogenic milieu that has been previously well-described in central nervous system neoplasms. Regulation of the endothelial cell actin cytoskeleton Actin is a 375 amino acid protein which polymerizes into alpha-helical microfilaments. Six actin isoforms exist with beta-actin occurring most commonly in endothelial cells, pericytes and fibroblasts, and alpha-actin occurring in vascular smooth muscle cells, cardiac and skeletal muscle. Actin is known to exist in a variety of structures and forms in many different cell types. In vascular endothelial cells, actin is compiled into several morphologically and functionally distinctive structures including: (1) short bundles in microvilli and stereocilia, (2) cortical actin stress fibers, (3) focal cell-matrix adhesion sites, (4) contractile rings, (5) cellular leading edge, (6) cell surface invaginations, (7) filopodia, (8) microspikes protruding from the cell surface, (9) cellular membrane ruffles and lamellipodia, and (10) networks of highly organized filaments traversing the cortical cytoplasm [4, [36] [37] [38] [39] [40] [41] [42] [43] . Cellular actin in its filamentous form (F-actin) is a dynamic protein that is continually shortening or depolymerizing at one end, while simultaneously growing (repolymerizing) at the other by a process called "treadmilling." The equilibrium between the F-and G-actin pools is a complex process involving several regulatory proteins.
Actin stress fibers are important in maintaining cellular shape and structural integrity. In tissue culture, they have been shown to run horizontally, in parallel with the cell membrane attached to the culture disk suface. In situ, actin stress fibers run parallel to the direction of blood flow, thus protecting the cell from flow-related shearing forces.
Dissolution of actin stress fiber networks in response to environmental stimuli causes cells to contract in volume and "round up" in shape. Specific actin cytoskeletal .changes have now been defined for perturbations involving histamine exposure, oxidant injury, oxyhemoglobin exposure, and ATP depletion [45] [46] [47] [48] [54] [55] [56] [57] [58] . In addition, recent studies have shown that assembly of actin stress fibers, cortical networks and focal adhesions occurs rapidly in the presence of a ras-related GTP-binding protein designated rho [38] . Rac, a related GTP-binding protein, has been shown to increase actin accumulation in membrane "ruffles." cell surface microspikes, and increased micropinocytotic activity [39] . The Gprotein Rab is believed to serve as a regulatory factor in the endocytotic pathway [55] . [4, 16, 35-37, 39, 56, 58] . The calcium signalling motif postulated for electrically inexcitable vascular endothelial cells is initiated by agonist binding to a specific surface membrane receptor (VEG/PF-tyrosine kinase). A G-protein intermediate (rho, rac or rab) then activates phospholipase C (PLC) resulting in the release of the soluble messengers, inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 activates a specific receptor and releases calcium from the endoplasmic reticulum into the cytoplasm. DAG increases actin nucleation and influences cytoskeletal assembly [56] . Transient elevations in cytosolic Ca++ therefore result in alterations in cytocontractile proteins and consequent cellular deformation [12-15, 23, 32, 36, 57] .
We previously hypothesized that a VEG/PF-induced increase in intracellular calcium concentration could lead to endothelial cytoskeletal reorganization, resulting in cellular contraction and distortion, opening of interendothelial clefts, and subsequent extravasation of plasma fluid and proteins into the tumor interstitium (edemagenesis) [13] [14] [15] [16] [17] 28, 29] . This direct calcium-cytocontractile relationship was recently observed using realtime laser scanning confocal epifluorescence microscopy (LSCEM) employing a calcium probe (fluo-3), and optical disc image aquisition and storage. VEG/PF-induced cytosolic calcium release was readily visualized, and correlated with a dynamic change in endothelial cell shape including cellular shrinkage and "rounding up" reminiscent of that observed in the static rhodamine-phalloidin images (Figures 6A-C The efficacy of dexamethasone in the treatment of peritumoral vasogenic edema is widely recognized [59] [60] [61] [62] [63] [64] [65] . Clinical improvement is associated with a resolution of edema on CT images, and tumor enhancement related to increased microvascular permeability diminishes considerably after dexamethasone treatment. Despite its wide usage, the mechanism dexamethasone's beneficial effects has remained uncertain. Given the causal role proposed for VEG/PF in the pathogenesis of vasogenic edema, it is reasonable to consider whether dexamethasone's efficacy relates to an influence on VEG/PF expression by tumor cells, or VEG/PF receptor expression and other related VEG/PF-induced endothelial cell events. Dexamethasone inhibition of. VEG/PF expression in cultured human malignant glioma cells has previously been reported [11] . Indeed, preincubation of endothelial cells with dexamethasone for two hours completely abolishes VEG/PFinduced cytosolic calcium transients [ 16] . The latter observation led us to hypothesize that dexamethasone is able to close the blood-tumor barrier by preventing VEG/PF-induced cytoskeletal contraction [14, 15] . The data collected thus far appear to support that hypothesis.
SUMMARY
These observations newly describe a rapid change in endothelial actin cytoskeletal conformation in response to VEG/PG perturbation. The resultant induction of endothelial cell contraction and widening of the interendothelial spaces is reminiscent of changes induced by other potent mediators of microvascular permeability. VEG/PF-induced changes could be prevented by preincubation of endothelial cells with a polyclonal anti-VEG/PF IgG antibody, and by pretreatment with dexamethasone. These findings support a specific permeabilityinducing effect ofVEG/PF on endothelial cell barriers. Rapidly proliferating endothelial cells responded more dramatically to VEG/PF perturbation than did slowly growing cells. Tumor endothelial cells, perhaps in response to VEG/PF stimulation, would be expected to show an enhanced proliferation rate. It is compelling to consider a relationship between active endothelial cell proliferation and VEG/PF receptor up-regulation. We have briefly reviewed the literature regarding the most relevant signal transducing pathways linking VEG/PF binding to its tyrosine kinase receptor, the induction of cytosolic calcium ion transients, and ultimately, to our hypothesized action for VEG/PF upon the endothelial actin cytoskeleton.
